Sector comparison

  United Therap...Exact Science...Insmed Inc.Incyte Corpor...Nasdaq 100
Overview  
ISIN  US91307C1027US30063P1057US4576693075US45337C1027US6311011026
Market Capitalization
13.28 bill. EUR7.68 bill. EUR12.89 bill. EUR10.99 bill. EUR-
Shares Outstanding
44.91 mill.185.76 mill.181 mill.193.52 mill.-
Dividend per Share*
- - - - -
Dividend Yield
-----
P/E Ratio
12.21--387.56-
P/E Ratio (with EPS Diluted)*
14.32-10.05-12.40460.47-
Free Float
---41.80%-
Performance  
Exchange  NASDAQNASDAQNASDAQNASDAQIndices Nasdaq
1 Week
+1.60%+0.47%+6.43%-12.82%+1.96%
1 Month
-12.86%-8.38%-1.94%-11.94%-10.41%
3 Months
-14.95%-25.16%+5.31%-10.65%-9.95%
YTD
-8.47%-19.59%+12.64%-10.22%-5.71%
1 Year
+36.97%-21.71%+202.37%+6.24%+11.25%
3 Years
+75.04%-29.59%+236.38%-16.60%+40.33%
5 Years
+300.87%+6.38%+401.74%-11.88%+165.08%
Fundamentals  2024202420242024-
Accounting Standard  US GAAPUS GAAPUS GAAPUS GAAP-
Revenues (in mill.)
2,877.4000 USD2,758.8670 USD363.7070 USD4,241.2170 USD-
Revenues Growth Rate
23.63%10.37%19.17%14.76%-
EBITDA (in mill.)
- - - - -
Operating Result (in mill.)
1,377 USD-1,048.7030 USD-878.2520 USD61.3660 USD-
Income Before Taxes (in mill.)
1,539 USD-1,036.1610 USD-910.0650 USD316.6300 USD-
Net Income (in mill.)
1,195.1000 USD-1,028.8570 USD-913.7720 USD32.6150 USD-
Net Income Growth Rate
21.35%403.97%21.91%-94.54%-
Earnings per Share
26.44 USD-5.59 USD-5.57 USD0.16 USD- USD
Total Equity (in mill.)
6,444 USD2,402.2490 USD285.3790 USD3,447.6280 USD-
Equity Ratio
87.51%40.52%14.09%63.33%-
Return on Equity
18.55%-42.83%-320.20%0.95%-
Book Value per Share
143.48 USD12.93 USD1.58 USD17.82 USD-
Total Assets (in mill.)
7,364 USD5,928.1390 USD2,025.2310 USD5,444.3220 USD-
Return on Assets
16.23%-17.36%-45.12%0.60%-
Operating Cash Flow (in mill.)
1,327.1000 USD210.5360 USD-683.8820 USD335.3370 USD-

 * Latest financial year